Oncology

For over two decades, our clinical research solutions have empowered drug developers to advance and commercialize innovative oncology therapies. Delivering success in such highly complex therapeutic areas requires deep scientific understanding, therapeutic expertise, and an unwavering commitment to patient-centered research.

Leading
the science behind
life-saving cancer therapies.

360+

Successful Studies

(Across all clinical phases)

900+

Sites

14500+

Subjects/Patients-

Proven experience with a wide range of drug molecules

Leading with unparalleled expertise in multiple indications

Cliantha has conducted trials in Carcinoma, Leukemia, Lymphoma, Myeloma, and Sarcoma involving:

Advanced Epithelial Tumors
Breast
Diffuse large B-cell lymphoma
Gastrointestinal – Colon, Rectum, Stomach, GIST
Head and Neck
Kidney
Lung
Ovarian
Prostate
Thyroid
Tumours having mutations, e.g., BRCA, HRR, etc.
Others
2 GCP/GLP Compliant laboratories- Ahmedabad, India and Toronto, Canada
State-of-the-art infrastructure – LCMS/MS, ICP-MS, MSD/ECL platforms and more
950+

Validated assays

50+

New Methods Evaluated Every Year

1.2+

Million Sample Analysis Capacity

Explore our Bioanalytical Laboratory Services

Explore our end-to-end services

End-to-end solutions

Site Network

Patient Recruitment

Regulatory Services

Decentralized Clinical Trials (DCT)

TO ACCELERATE YOUR ONCOLOGY PIPELINE
- CONTACT US.

Research delivered with Integrity

CONTACT US
Cliantha Research Logo

Privacy Policy

Cookie Policy

© 2026 All Rights Reserved Cliantha Research.